Advertisement

Topics

Intellect Neurosciences, Inc. Company Profile

09:37 EST 22nd November 2017 | BioPortfolio


News Articles [80 Associated News Articles listed on BioPortfolio]

ProMIS Neurosciences: ProMIS Neurosciences Independent Director Anthony J. Giovinazzo Recognized with Inaugural Bloom Burton Award for Innovation in Canadian Healthcare

ProMISTM Neurosciences, Inc. NEWS RELEASE TSX: PMN TORONTO, ONTARIO and CAMBRIDGE, MA - September 21, 2017 - ProMIS Neurosciences, Inc., a company focused on the discovery and development of preci...

ProMIS Neurosciences: ProMIS Neurosciences Completes First Closing of Private Placement

/NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, ONTARIO - August 9, 2017 - ProMIS Neurosciences Inc. ("ProMIS" or the "Company") (TSX:PMN; OTCPK:A...

ProMIS Neurosciences: ProMIS Neurosciences Announces CDN$3 Million Best-Efforts Private Placement

/NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, ON - July 20, 2017 - ProMIS Neurosciences Inc. ("ProMIS" or the "Company") (TSX:PMN; OTCPK:ARFX.F;...

ProMIS Neurosciences: ProMIS Neurosciences Increases Size of Private Placement to $6 Million

/NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, ONTARIO - August 2, 2017 - ProMIS Neurosciences Inc. ("ProMIS" or the "Company") (TSX:PMN; OTCPK:A...

Minerva Neurosciences, Inc.: Minerva Neurosciences Names Dr. Justine Lalonde as Senior Vice President, Product Strategy

WALTHAM, Mass., 2017-10-31 13:00 CET (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat centr...

Minerva Neurosciences, Inc.: Minerva Neurosciences, Inc. to Offer Common Shares

WALTHAM, Mass., 2017-06-27 22:10 CEST (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company, today announced its intention to offer and sell 5,00...

ProMIS Neurosciences: ProMIS Neurosciences Announces Second Quarter 2017 Results

TORONTO and CAMBRIDGE, Mass., Aug. 11, 2017 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. ("ProMIS" or the "Company"), a company focused on the discovery and development of precision treatments f...

Minerva Neurosciences, Inc.: Minerva Neurosciences Announces Pricing of Public Offering of Common Stock

WALTHAM, Mass., 2017-06-29 00:45 CEST (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten publi...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Myobloc [Solstice Neurosciences, LLC]

Myobloc (rimabotulinumtoxinB) Injection

PubMed Articles [104 Associated PubMed Articles listed on BioPortfolio]

Flowers for Algernon: The ethics of human experimentation on the intellectually disabled.

Flowers for Algernon is a novel written in 1966 by Daniel Keyes. Since its publication, it has received significant critical acclaim, earning a Nebula science-fiction award, and was also adapted into ...

The surge of predatory open-access in neurosciences and neurology.

Predatory open access is a controversial publishing business model that exploits the open-access system by charging publication fees in the absence of transparent editorial services. The credibility o...

NeurHistAlert 23.

End-of-Volume Editorial Board.

Clarification by Richard Leblanc.

Clinical Trials [10 Associated Clinical Trials listed on BioPortfolio]

Heart Failure, Functional and Cognitive Decline, and Psychiatric Symptoms in Nursing Home Patients

Heart failure is very common in the elderly, in whom it may lead to functional and intellectual problems. Functional problems include loss in the ability to perform basic tasks of daily li...

Enhancing Social Interaction With an AlterEgo Artificial Agent

The objective of AlterEgo is the creation of an interactive cognitive architecture, implementable in various artificial agents, allowing a continuous interaction with patients suffering fr...

Treatment of Huntington's Chorea With Amantadine

Huntington's disease is a chronic disorder passed on through genetic autosomal dominant inheritance. The condition usually begins between the ages of 30 and 50 years and it is characteriz...

Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies

The project will improve scientific knowledge regarding a recent law applying potentially to every french driver. It will give for the first time an indication on the impact of alerting tr...

Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers

The development of a new automated method of measurement of the volume of the hippocampus allows confirming these results in patients presenting with pre-dementia AD, treated with donepezi...

Companies [54 Associated Companies listed on BioPortfolio]

Intellect Neurosciences, Inc.

Merz Neurosciences

Merz Neurosciences is a division of Merz North America, a specialty healthcare company that develops and commercializes treatment solutions in aesthetics, dermatology and neurosci...

Intellect SEEC

Intellect Resources

Intellect Resources is a search firm specializing in full-time and contract placements in the healthcare IT industry, primarily in core healthcare information systems implementati...

Nautilus Neurosciences, Inc.

Nautilus Neurosciences, Inc. is a neurology-focused specialty pharmaceutical company committed to providing the healthcare community with medically relevant products and services ...

More Information about "Intellect Neurosciences, Inc." on BioPortfolio

We have published hundreds of Intellect Neurosciences, Inc. news stories on BioPortfolio along with dozens of Intellect Neurosciences, Inc. Clinical Trials and PubMed Articles about Intellect Neurosciences, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Intellect Neurosciences, Inc. Companies in our database. You can also find out about relevant Intellect Neurosciences, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record